US 11932867
Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene
granted A61KA61K35/28A61K48/00
Quick answer
US patent 11932867 (Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene) held by The Regents of the University of Colorado, a Body Corporate expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K35/28, A61K48/00, A61K48/005, A61P